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Isolated deficiency of cytochrome c oxidase (COX) ismost frequently
caused by mutations in SURF1 gene and manifest as fatal Leigh
syndrome. Exact function of Surf1 protein (Surf1p) is still unknown
but itmaybe involved in anearly stepof assemblyduring the association
of CoxII subunit with CoxI–CoxIV–CoxVa subassembly. Absence of
Surf1p leads to decreased content and activities of COX, accumulation of
COX assembly intermediates and decrease of mitochondrial membrane
potential. The aim of study was to describe how SURF1 mutations
influence protein and transcript level of OXPHOS genes and if there are
specific changes in other non-mitochondrial genes. For experiments
were used cell fibroblast lines of 9 patients with SURF1mutations and of
5 controls. Protein levels in cell homogenates and in isolated
mitochondria were analysed by SDS-PAGE and 2D BN/SDS-PAGE
combined with immunobloting using specific antibodies to subunits of
the respiratory chain complexes (RCC). Expression data were obtained
using Agilent humanwhole genome array 44K. Analysis of COX subunits
revealed similar changes in the content of CoxI, CoxII, CoxIII and CoxIV in
patient cells and mitochondria that were decreased to 13%–50% of
controls while the CoxVa was less affected, 63% of controls. 2D analysis
revealed accumulated CoxVa in the form of unassembled monomer or
CoxVa–CoxIV heterodimer but neither of these subunitswere present in
80 kDa intermediate containingCoxI. In response to COXdeficiencyboth
the cellular and mitochondrial content of RCC I and III was increased to
130% and 142% of controls. Expression profiles did not reveal significant
and consistent changes inmRNA levels of OXPHOS subunit genes or pro-
mitochondrial regulatory genes such as PGC1A,NRF1 or TFAM. Our study
indicates that observed compensatory changes result from posttran-
scriptional regulation.
Suported by: GACR 303/07/0781; Ministry of Education CR
1M6837805002, AV0Z 50110509.
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Complex I (NADH:ubiquinone oxidoreductase, CI) is the largest,
the most complex and the most crucial of the five multisubunit
enzymes which belong to the OXPHOS system located in the inner
mitochondrial membrane. The function of CI is to transfer electrons
from NADH to ubiquinone, a process during which proton force is
generated to enable ATP synthesis. NADH:ubiquinone oxidoreductase
is composed of 46 protein subunits, which belong either to
flavoprotein fraction, iron–sulphur fraction or hydrophobic fraction.
Seven of these subunits are encoded by mitochondrial genes, with the
remaining ones being encoded by nuclear genes. The highest level of
their expression in humans is observed in brain, heart, skeletal
muscles, kidneys and liver. Mutations in complex I subunits are
associated with CI activity and a wide spectrum of mitochondrial
disorders. Being responsible for 30% of all respiratory chain disorders
in humans, this particular syndrome is inherited in autosomal
recessive manner or it may be chromosome X-linked. The following
genes: (1) mitochondrial genes: MTND1, MTND2, MTND3, MTND4,
MTND4L, MTND5 and MTND6; (2) nuclear genes: NDUFS1, NDUFS2,
NDUFS3, NDUFS4, NDUFS6, NDUFS7, NDUFS8, NDUFV1 and NDUFV2
have been selected and analysed. All these genes are characterised by
the same criteria. Firstly, they play the most important role in proper
functioning of complex I. Secondly, they are highly conserved in the
course of evolution. Finally, 55 different mutations have already been
found in them (including mononucleotide substitutions, deletions,
duplication, and inversion), mutations which cause such diseases as
Leigh syndrome (LS), LHON, MELAS, Alzheimer disease and Parkinson
disease. We present the results of molecular analysis of 18 Polish
patients, with clinically and biochemically confirmed CI deficiency.
The experiments involved three stages: isolation of cDNA from
fibroblasts or genomic DNA from muscle biopsies and/or blood; PCR
analysis; direct sequencing. In one patient m.3697G>A mutation,
associated with mitochondrial cytopathy, was found in MTND1 gene.
In other 5 patients with LS 3 different mtDNA mutations were found:
m.10191T>C (MTND3), m.13513G>A (MTND5), and m.14487T>C
(MTND6). Additionally three polymorphic variants were observed in
two other patients: p.V4V, p.G66G (NDUFS4) and p.A280V (NDUFS2).
doi:10.1016/j.bbabio.2010.04.168
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De Meirleir et al. (Pediatr. Neurol. 13: 242–246, 1995) reported a
2.5-year-old boy with bilateral striatal lesions presumed to be the
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result of a point mutation (T to C) at nucleotide position 8851 of the
mitochondrial DNA (mtDNA). This mutation changes a highly
conserved tryptophane residue to arginine at amino acid position
109 of the subunit a of mitochondrial F1FO-ATP synthase, a complex
which provides most of the cellular ATP in humans. Nothing is
known on the consequences of the T8851C mutation on the
mitochondrial ATP synthase. To gain insight into the primary
pathogenic mechanisms induced by T8851C, we have investigated
the consequences of this mutation on the ATP synthase of yeast
where the protein homologous to subunit a (referred to as Atp6p) is
also encoded by the mtDNA. The modified yeast exhibited a very
slow growth phenotype on non-fermentable carbon sources, both at
28 °C (the optimal temperature for growing yeast) and at 36 °C. In
vitro, mitochondria from T8851C yeast grown at 28 °C showed a 60%
deficit in ATP production, while those prepared from the mutant
grown at 36 °C had an ATP synthesis activity below 5% that of the
wild type. The mutated F1FO complex was correctly assembled, at
both temperatures, and had a very poor ATPase activity (10% that
of the wild type), both in mitochondria and after purification.
Electron microscopy revealed that many of the mitochondrial
matrices in T8851C yeast grown at 36 °C exhibited septae made of
apposed inner mitochondrial membranes. Another anomaly was an
increased mitophagic activity, presumably in response to the
T8851C-induced damaging of mitochondria. Thus, in addition to a
bioenergetic deficit, alterations in mitochondrial dynamics and
homeostasis may also participate in the pathogenic mechanism
induced by T8851C.
doi:10.1016/j.bbabio.2010.04.169
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Mitochondrial disease is an energy metabolic disorder with
various organ involvements. Iron is widely known to be one of the
most important nutriments required for normal brain development
and several essential metabolic functions. We retrospectively studied
the laboratory data on iron deficiency (ID) in 69 children with
mitochondrial respiratory chain complex (MRC) defects by biochem-
ical enzyme assay using muscle tissue. We analyzed the differences
between groups of mitochondrial disease based on the presence of ID.
ID has higher prevalence in children with mitochondrial disease than
in the normal population. There were 6 (9%) patients with low
hemoglobin, 12 (17%) with low serum ferritin, and 22 (32%) with low
transferrin saturation levels among children with MRC defects. In
comparisons between the ID and the non-ID group of MRC-defect
patients, the frequency of MRC I defect was significantly higher in the
ID group while that of MRC IV defect was higher in the non-ID group.
Abnormal brain magnetic resonance imaging (MRI) findings were
more frequently detected in the ID group. The incidence of failure to
thrive and gastrointestinal symptoms were significantly higher in the
ID group. Early diagnosis and proper treatment of ID are recom-
mended. Especially in cases with risk factors such as failure to thrive
or gastrointestinal manifestation, active evaluation of ID should be
encouraged.
doi:10.1016/j.bbabio.2010.04.170
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Cytochrome c oxidase (COX, CIV) is one of the complexes of the
OXPHOS system located in the inner mitochondrial membrane and
catalyzing the last step of electron's transfer from cytochrome c to
molecular It is composed of 13 subunits encoded by
mitochondrial and nuclear DNA. A correct assembly and function of
COX require a substantial number of the nuclear, ancillary proteins,
including SCO2, which is involved in the transport and incorporation
of the cooper ions to the CuA enzymatic site on COXII subunit. Human
SCO2 gene is located on the chromosome 22q13, and contains two
exons. Only the 801 bp fragment of exon 2 undergoes translation into
266 amino acid protein. Mutations in the SCO2 gene lead to serious
damage of the protein resulting in severe COX deficiency observed
mainly in muscle, heart and brain. The common substitution,
g.1541G>A (p.E140K) was identified at least on one allele in all so
far reported patients with COX deficiency. In the group of 23 Polish
patients, the common substitution was found on 84% of the studied
alleles. The clinical features of the disease associated with SCO2
deficiency include early onset, fatal hypertrophic cardiomyopathy
with respiratory insufficiency, encephalopathy, hypotonia and meta-
bolic acidosis. The aim of this study was to characterize the molecular
background of the disease in three patients from two unrelated
families with clinically and biochemically recognized cytochrome c
oxidase deficiency. Here we present patients with the same genotype,
comprising the common mutation, g.1541G>A and a new, not
described in the literature, molecular variant g.1653T>C. The new
variant affects the highly conserved methionine at 177 position of the
SCO2 protein (p.M177T) and was not found on 600 control alleles.
Additionally, g.1653T>C substitution was predicted by SIFT BLink
programme as a pathogenic mutation. Our findings indicate that the
compound heterozygous genotype, p.M177T/p.E140K, is responsible
for clinical manifestation of destroyed SCO2 protein.
The study was partly supported by the CMHI project no. S11/2009
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doi:10.1016/j.bbabio.2010.04.171
4P.10 Impaired mitochondrial energetic in patients harbouring
SURF1mutations is caused by uncoupling of cytochrome c oxidase
Petr Pecina, Alena Pecinova, Nikola Kovarova, Martin Kalous,
Ivan Miksik, Josef Houstek
Institute of Physiology and Center for Applied Genomics, AS CR,v.v.i.,
Prague, Czech Republic
E-mail: petr.pecina@gmail.com
Leigh syndrome is most frequently caused by mutations of SURF1
gene, which encodes cytochrome c oxidase (COX) specific assembly
factor. Our previous studies suggested that fibroblasts from patients
harbouring SURF1 mutations accumulate incomplete forms of COX
lacking several small nuclear-encoded subunits with decreased H+/e
stoichiometry. In experiments aimed at detailed characterization of the
mitochondrial energetics, we observed 30–50% decreased respiratory
capacity available for ATP synthesis (RCRP). When using COX-specific
substrates ascorbate + TMPD, the RCRP was 7-fold lower than in
controls, suggestive of deficient proton pumping of COX in patient
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